AUDIOCURE PHARMA
AudioCure Pharma is a pharmaceutical company with a focus on hearing impairments. Operational since 2012, AudioCure was founded by Professor Hans Rommelspacher; a clinician and academic who has dedicated his career to the discovery and preclinical development of drug candidates. He is joined by highly skilled scientists and executives as well as a tight-knit network of academic partners, internationally renowned advisors and strategic investors. AudioCure is based in Berlin, Germany. Their offi... ce is located in a peaceful courtyard in the central area of Mitte. As such, they benefit from being within easy reach of the main train station and many other Berlin high-tech companies and universities while also enjoying the hustle and bustle of this vibrant capital city. They have close ties to the Charité University which allows for a close interaction with the experts of this world renowned institution. Their front-runner compound: AC102, is currently in late stage preclinical development for the treatment of acute noise-induced hearing loss having successfully demonstrated preclinical proof of concept in 2016.
AUDIOCURE PHARMA
Social Links:
Industry:
Biotechnology Education Emergency Medicine Therapeutics
Founded:
2010-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.audiocure.com
Total Employee:
1+
Status:
Active
Contact:
+49 (30) 221 8397 14
Email Addresses:
[email protected]
Total Funding:
9 M EUR
Technology used in webpage:
LetsEncrypt Nginx CrUX Dataset CrUX Top 10m Common Name Invalid Infomaniak Network
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Current Employees Featured
Founder
Investors List
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Series A - AudioCure Pharma
MED-EL
MED-EL investment in Series A - AudioCure Pharma
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Seed Round - AudioCure Pharma
Jürgen Schumacher
Jürgen Schumacher investment in Seed Round - AudioCure Pharma
Official Site Inspections
http://www.audiocure.com
- Host name: w00.rzone.de
- IP address: 81.169.145.64
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
More informations about "AudioCure Pharma"
About Us | Audiocure
AudioCure is based in Berlin, Germany. Our office is located in a peaceful courtyard in the central area of Mitte. As such, we benefit from being within easy reach of the main train station and …See details»
Audiocure | Towards better hearing
AudioCure is dedicated to the development of drug treatments for hearing disorders with a high unmet medical need. By protecting and restoring the cellular key players that are critical to the hearing process, our therapeutic approach …See details»
AudioCure Pharma - Crunchbase Company Profile
AudioCure Pharma secured funding from InfectoPharm to support the clinical development of AC102, a drug aimed at treating sudden hearing loss. This funding round was confirmed and aimed at advancing the company's …See details»
Investors - Audiocure
HTGF – High-Tech Gründerfonds HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial …See details»
AudioCure Pharma Secures Funding from InfectoPharm to …
Feb 13, 2025 AudioCure Pharma is a Berlin-based biopharmaceutical company focused on developing innovative treatments for hearing loss and related auditory conditions. The …See details»
AudioCure 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for AudioCure. Use the PitchBook Platform to explore the full profile.See details»
AudioCure Pharma Company Profile - Office Locations ... - Craft
AudioCure Pharma has 5 employees at their 1 location and $10.58 m in total funding,. See insights on AudioCure Pharma including office locations, competitors, revenue, financials, …See details»
AudioCure Pharma - VentureRadar
"AudioCure Pharma concentrates on the clinical development of drug candidates in neurodegenerative disease indications with a high unmet medical need. The lead candidate is …See details»
AudioCure Pharma (AudioCure Pharma GmbH) - startbase.com
Sector: Life Science & Healthcare Company Stage: Startup Stage Business Model: Manufacturing Customer Focus: B2B Founding Year: 2010 Team Size: 1-10 Employees Handelsregister: …See details»
AudioCure Pharma GmbH - VentureRadar
AudioCure Pharma GmbH Location: Germany Founded in 2010 "AudioCure is dedicated to the development of drug treatments for hearing disorders with a high unmet medical need.See details»
AudioCure Pharma - Funding, Financials, Valuation & Investors
AudioCure is dedicated to the development of drug treatments for hearing disorders with a high unmet medical need.See details»
AudioCure • life science startup | HTGF
AudioCure Pharma is an innovative clinical-stage pharmaceutical company focused on developing treatments for audiological and neurological disorders with a high unmet medical need.See details»
InfectoPharm Invests in AudioCure to Advance Innovative Hearing …
AudioCure Pharma, a Berlin-based start-up supported by investors, is driving forward research and development. Now, InfectoPharm, a successful medium-sized company, is joining as a …See details»
AC102 - Audiocure
AC102 Prevents Hair Cell Death and Restores Connections Between the Inner Ear and the Brain Inner ear sensory cells (hair cells) act as sound amplifiers and transmit sound signals via the …See details»
New Hope for Sudden Hearing Loss: AudioCure Secures Funding
Feb 19, 2025 The drug has already successfully passed human safety and tolerability tests in Phase 1 trials. AudioCure is also developing treatments for tinnitus and solutions to support …See details»
Our Technology - Audiocure
A disease modifying novel molecule AudioCure Pharma develops novel pharmaceutical therapies for the prevention and treatment of a range of hearing impairments with high, unmet medical …See details»
AudioCure Pharma Awarded for Therapeutic Small Molecule for …
Dec 7, 2023 AudioCure Pharma GmbH has been awarded for its innovative compound AC102 by the Hearing Technology Innovator Awards, honoring technological innovation and …See details»
Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma …
Nov 26, 2024 Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the studySee details»
News in Brief - Audiocure
Sep 22, 2017 AudioCure Pharma, a Berlin-based start-up supported by investors, is driving forward research and development. Now, InfectoPharm, a successful medium-sized company, …See details»
Living With Hearing Loss - Audiocure
At AudioCure, we are dedicated to filling this gap. Our scientists have developed a compound called AC102 with the ability to address the damage to the cells that are critical to the hearing …See details»